U.S. markets close in 5 hours 1 minute

Tetra Bio-Pharma Inc. (TBPMF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1226-0.0014 (-1.09%)
As of 10:39AM EDT. Market open.
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 10/26/2020
Current
8/31/20205/31/20202/29/202011/30/20198/31/2019
Market Cap (intraday) 5
38.61M40.93M43.97M72.33M59.29M48.82M
Enterprise Value 3
30.19M28.31M35.29M68.17M55.10M47.85M
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
N/AN/AN/A618.84584.0735.27
Price/Book (mrq)
1.521.281.773.322.752.61
Enterprise Value/Revenue 3
N/AN/AN/AN/AN/AN/A
Enterprise Value/EBITDA 6
-1.74-5.86-8.05-15.00-15.82-14.11

Trading Information

Stock Price History

Beta (5Y Monthly) 1.66
52-Week Change 3-27.40%
S&P500 52-Week Change 311.29%
52 Week High 30.6045
52 Week Low 30.0940
50-Day Moving Average 30.1238
200-Day Moving Average 30.1594

Share Statistics

Avg Vol (3 month) 3110.8k
Avg Vol (10 day) 3107.46k
Shares Outstanding 5281.83M
Float 243.86M
% Held by Insiders 115.96%
% Held by Institutions 10.87%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:2
Last Split Date 3Jun 22, 2014

Financial Highlights

Currency in CAD.

Fiscal Year

Fiscal Year Ends Nov 29, 2019
Most Recent Quarter (mrq)Aug 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-30.24%
Return on Equity (ttm)-57.77%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)N/A
Diluted EPS (ttm)-0.0290
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)N/A
Total Cash Per Share (mrq)N/A
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.36
Book Value Per Share (mrq)0.09

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A